Earnings calls

GEMAROMA concall ledger

Every earnings call for GEMAROMA — management tone, guidance, KPIs and promise tracking, quarter by quarter.

GEMAROMA · 3 transcripts · Chemicals · latest Q4 FY26

Q4 FY26Published 22 May 2026Call held 22 May 2026

GEMAROMA Q4 FY26 Earnings Call Transcript & Analysis

Standalone Revenue₹112 crStandalone EBITDA₹15 crStandalone EBITDA Margin13.4%Standalone PAT₹12 cr

Standalone Revenue ₹112 cr; Standalone EBITDA ₹15 cr; Standalone EBITDA Margin 13.4%. Q4 FY26 standalone revenue grew 34% sequentially to INR 112 crores.

Read full transcript & analysis

Q3 FY26Published 27 Jan 2026Call held 27 Jan 2026

GEMAROMA Q3 FY26 Earnings Call Transcript & Analysis

Consolidated Revenue₹78.9 crConsolidated EBITDA₹7 crConsolidated EBITDA Margin8.9%Consolidated Gross Margin23%

Consolidated Revenue ₹79 cr; Consolidated EBITDA ₹7 cr; Consolidated EBITDA Margin 8.9%. Consolidated revenue from operations stood at INR 78.9 crores in Q3 FY26.

Read full transcript & analysis

Q2 FY26Published 14 Nov 2025Call held 14 Nov 2025

GEMAROMA Q2 FY26 Earnings Call Transcript & Analysis

Revenue₹89.5 crEBITDA₹3 crEBITDA Margin3.4%Net Profit₹5.4 crPAT Margin3.1%

Revenue (Q2 FY26) ₹90 cr; EBITDA (Q2 FY26) ₹3 cr; EBITDA Margin (Q2 FY26) 3.4%. Successful IPO listing on NSE and BSE on August 26, 2025.

Read full transcript & analysis